Aarkstore - Vaginal Atrophy (Atrophic Vaginitis) - Pipeline

1. Pharmaceutical and Healthcare Market Research Report Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2014 For More Information Visit : www.aarkstore.com

2. Summary Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2014, provides an overview of the Vaginal Atrophy (Atrophic Vaginitis)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Vaginal Atrophy (Atrophic Vaginitis), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Vaginal Atrophy (Atrophic Vaginitis) and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. For More Information Visit : www.aarkstore.com

3. Scope - The report provides a snapshot of the global therapeutic landscape of Vaginal Atrophy (Atrophic Vaginitis)- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Vaginal Atrophy (Atrophic Vaginitis) and enlists all their major and minor projects- The report summarizes all the dormant and discontinued pipeline projects - A review of the Vaginal Atrophy (Atrophic Vaginitis) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages Browse full report or Sample Request @ • http://www.aarkstore.com/pharmaceuticals-healthcare/100597/vaginal-atrophy-atrophic-vaginitis-pipeline-review-h2-2014 For More Information Visit : www.aarkstore.com

4. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage- Develop strategic initiatives by understanding the focus areas of leading companies- Identify and understand important and diverse types of therapeutics under development for Vaginal Atrophy (Atrophic Vaginitis)- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline- Devise corrective measures for pipeline projects by understanding Vaginal Atrophy (Atrophic Vaginitis) pipeline depth and focus of Indication therapeutics- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline For More Information Visit : www.aarkstore.com

5. Table of Content IntroductionREPORT COVERAGEVaginal Atrophy (Atrophic Vaginitis) OverviewTherapeutics DevelopmentPipeline Products for Vaginal Atrophy (Atrophic Vaginitis) - OverviewPipeline Products for Vaginal Atrophy (Atrophic Vaginitis) - Comparative AnalysisVaginal Atrophy (Atrophic Vaginitis) - Therapeutics under Development by CompaniesVaginal Atrophy (Atrophic Vaginitis) - Pipeline Products GlanceLate Stage ProductsClinical Stage ProductsEarly Stage ProductsVaginal Atrophy (Atrophic Vaginitis) - Products under Development by CompaniesVaginal Atrophy (Atrophic Vaginitis) - Companies Involved in Therapeutics DevelopmentFoamix Ltd.Pantarhei Bioscience BV For More Information Visit : www.aarkstore.com

6. List of Tables Number of Products under Development for Vaginal Atrophy (Atrophic Vaginitis), H2 2014Number of Products under Development for Vaginal Atrophy (Atrophic Vaginitis) - Comparative Analysis, H2 2014Number of Products under Development by Companies, H2 2014Comparative Analysis by Late Stage Development, H2 2014Comparative Analysis by Clinical Stage Development, H2 2014Comparative Analysis by Early Stage Development, H2 2014Products under Development by Companies, H2 2014Vaginal Atrophy (Atrophic Vaginitis) - Pipeline by Foamix Ltd., H2 2014Vaginal Atrophy (Atrophic Vaginitis) - Pipeline by Pantarhei Bioscience BV, H2 2014Vaginal Atrophy (Atrophic Vaginitis) - Pipeline by Hygeia Therapeutics, Inc., H2 2014Vaginal Atrophy (Atrophic Vaginitis) - Pipeline by EndoCeutics, Inc., H2 2014Vaginal Atrophy (Atrophic Vaginitis) - Pipeline by TherapeuticsMD Inc., H2 2014Vaginal Atrophy (Atrophic Vaginitis) - Pipeline by Peptonic medical AB, H2 2014 For More Information Visit : www.aarkstore.com

7. List of Figures Number of Products under Development for Vaginal Atrophy (Atrophic Vaginitis), H2 2014Number of Products under Development for Vaginal Atrophy (Atrophic Vaginitis) - Comparative Analysis, H2 2014Number of Products under Development by Companies, H2 2014Assessment by Monotherapy Products, H2 2014Number of Products by Top 10 Target, H2 2014Number of Products by Stage and Top 10 Target, H2 2014Number of Products by Top 10 Mechanism of Action, H2 2014Number of Products by Stage and Top 10 Mechanism of Action, H2 2014Number of Products by Top 10 Route of Administration, H2 2014Number of Products by Stage and Top 10 Route of Administration, H2 2014Number of Products by Top 10 Molecule Type, H2 2014Number of Products by Stage and Top 10 Molecule Type, H2 2014 For More Information Visit : www.aarkstore.com

8. Related Reports Sinusitis-Pipeline Insights, 2015 Oligodendroglioma-Pipeline Insights, 2015 Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)-Pipeline Insights, 2015 Fatty Liver Disease-Pipeline Insights, 2015 Skin And Skin Structure Infections by S.Pneumoniae-Pipeline Insights, 2015 Opioid-Induced Constipation (OIC)-Pipeline Insights, 2015 Female Infertility-Pipeline Insights, 2015 Optic Neuritis-Pipeline Insights, 2015 For More Information Visit : www.aarkstore.com

9. Follow Us https://www.facebook.com/aarkstoredotcom https://twitter.com/aarkstore https://plus.google.com/+Aarkstoredotcom/posts https://www.linkedin.com/company/aarkstore-enterprise For More Information Visit : www.aarkstore.com

10. Contact Us Office Address Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Mail us at contact@aarkstore.com 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 For More Information Visit : www.aarkstore.com